- info@corebiolabs.com
- 330-405-2623
- 330-405-0859
Diagnosing wound infections is a critical yet challenging task in wound care. Healthcare providers must navigate through a myriad of bacteria, viruses, and fungi to accurately identify the causative agents, especially in the 7 million U.S. patients suffering from chronic wounds. In these cases, infections can significantly hinder the healing process. Misdiagnosis or delayed diagnosis not only leads to severe complications, including pain and increased hospitalization, but also risks loss of function and mobility.
CoreBioLabs precisely analyzes wounds for 48 pathogens and 13 resistance markers simultaneously using advanced molecular identification techniques with the QuantStudio 12 Flex by ThermoFisher®. We proudly offer an option for in-house Antibiotic Susceptibility Testing. After positive culture growth, our BD Phoenix® system provides antimicrobial concentrations for detection of emerging resistance.
Resistance Markers:
CoreBioLabs addresses the intricate challenges of wound infection diagnosis with our state-of-the-art PCR testing:
At CoreBioLabs, we offer a revolutionary approach to wound infection diagnosis with our PCR testing services:
Enhanced Patient Outcomes: Early and accurate detection of wound infections leads to better treatment choices, improving healing times and reducing the risk of complications.
Embrace CoreBioLabs’ PCR testing services to overcome the complexities of wound infection diagnosis. Our advanced technology not only ensures precision and speed but also significantly improves patient outcomes. Choose CoreBioLabs for a future where wound care is guided by accuracy and efficiency, reducing healthcare costs and enhancing quality of life.
